29.07.2019 • News

Damages Reduced in Third Roundup Verdict

Damages Reduced in Third Roundup Verdict (c) Joerg Boethling/Alamy Stock Photo
Damages Reduced in Third Roundup Verdict (c) Joerg Boethling/Alamy Stock Photo

A third judge has slashed a jury’s damage award to a plaintiff in a lawsuit involving Monsanto’s glyphosate-based Roundup herbicide.

The award reduced last week by Judge Winifred Smith of the California Superior Court in Oakland was the largest payout so far, totaling more than $2 billion. Alva and Alberta Pilliod are now due to receive altogether $86.7 million in compensatory and punitive damages from Bayer, as Smith said the initial award was “excessive and unconstitutional.”

The German group called the third reduction “a step in the right direction” as it had the first two. However, said it it continues to believe that the verdict and damage awards conflict with the “extensive body of reliable science and conclusions of leading health regulators worldwide” that glyphosate-based herbicides can be used safely and that glyphosate per se is not carcinogenic

Rejecting Bayer’s arguments, the judge said there was “clear and convincing evidence that Monsanto made efforts to impede, discourage, or distort scientific inquiry and the resulting science,” Smith also rejected Bayer’s call for the judgment to be reversed.

While the couple will be required to formally accept the reduced awards, their lawyer called the overall result “a big win, even if it does not fairly capture the pain and suffering they experienced.”

The Pillod case was the third of three Monsanto trials Bayer has dealt with so far – with all of the plaintiffs alleging that Roundup caused their non-Hodgkin lymphoma. It is appealing all of them, with more than 13,000 still pending.

In the first case to come to trial, in 2018, school groundskeeper DeWayne Johnson was initially awarded $289 million. A judge later reduced the sum to $78 million. Earlier in July, Judge Vincent Chhabria cut a damage payment to another California man, Edward Hardeman, from $80 million to $25.3 million.

A fourth trial is scheduled to begin early next month in Monsanto’s US home base of St. Louis, Missouri. This will be the first outside California. According to reports, Monsanto has recruited Missouri-based “expert witnesses” to make its case in a place where it has century-old roots but where juries often hit companies with huge damages.

 

 

 

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read